Viewing Study NCT02691793


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2026-03-10 @ 11:37 PM
Study NCT ID: NCT02691793
Status: COMPLETED
Last Update Posted: 2022-06-15
First Post: 2016-02-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Evaluate the Safety and Efficacy of Sunitinib, in Subject With Refractory Solid Tumors
Sponsor: Samsung Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 2016-02-098
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators